Teknologi Kesihatan
Syarikat-syarikat Swiss membangunkan teknologi kesihatan
Membangunkan peranti perubatan, diagnostik dan platform perisian penjagaan kesihatan mendefinisikan sektor teknologi kesihatan. Garis masa kelulusan kawal selia dan peralihan model pembayaran semula Medicare secara berterusan menyuntik kecairan ke dalam ekuiti-ekuiti ini. Pada masa ini, Novartis AG mendominasi volum dagangan, manakala Inovio Pharmaceuticals, Inc. mencatatkan prestasi 24 jam terkuat. Jadual di bawah menyusun titik data teknikal dan asas yang penting.
Simbol | Permodalan pasaran | Harga | Perubahan % | Volum | Volum relatif | P/E | EPS cair TTM | Pertumbuhan EPS cair TTM YoY | Hasil dividen % TTM | Penarafan penganalisa |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.09 T CHF | 1,180 CHF | +23.56% | 1 | 0.31 | 46.38 | 25.44 CHF | +57.99% | 0.47% | Beli kuat |
| LLYEli Lilly and Company | 1.09 T CHF | 1,104.870 CHF | −5.56% | 6 | 0.13 | 43.42 | 25.44 CHF | +57.99% | 0.47% | Beli kuat |
 JNJJohnson & Johnson | 543.72 B CHF | 227.679 CHF | +3.11% | 12 | 0.87 | 41.32 | 5.51 CHF | −33.23% | 1.91% | Beli |
| JNJ.USDJohnson & Johnson | 543.72 B CHF | 261.25 USD | 0.00% | 177 | 0.35 | 39.63 | 5.51 CHF | −36.38% | 1.91% | Beli |
 4ABAbbVie, Inc. | 425.98 B CHF | 240.889 CHF | +13.10% | 1.35 K | 9.21 | 49.60 | 4.86 CHF | +360.13% | 2.35% | Beli |
| ABBVAbbVie, Inc. | 425.98 B CHF | 236.65 CHF | +1.24% | 20 | 0.30 | 48.72 | 4.86 CHF | +360.13% | 2.35% | Beli |
 RORoche Holding Ltd | 315.59 B CHF | 400.0 CHF | +0.25% | 64.81 K | 2.40 | 26.10 | 15.33 CHF | +30.49% | 2.69% | Beli |
| RHORoche Holding Ltd | 315.59 B CHF | 405.099 CHF | −0.76% | 15 | 0.73 | 26.43 | 15.33 CHF | +30.49% | 2.69% | Beli |
| ROPRoche Holding Ltd | 315.59 B CHF | 390.3 CHF | −0.36% | 1.44 M | 1.30 | 25.47 | 15.33 CHF | +30.49% | 2.48% | Beli |
| ROPRoche Holding Ltd | 315.59 B CHF | 386.324 CHF | −1.65% | 344 | 0.41 | 25.21 | 15.33 CHF | +30.49% | 2.48% | Beli |
 6MKMerck & Co., Inc. | 303.22 B CHF | 123.142 CHF | +4.32% | 16 | 0.65 | 150.44 | 0.82 CHF | −86.41% | 2.26% | Beli |
| MRK.USDMerck & Co., Inc. | 303.22 B CHF | 151.22 USD | 0.00% | 1.24 K | 0.89 | 154.43 | 0.82 CHF | −87.05% | 2.26% | Beli |
 NOVNNovartis AG | 245.77 B CHF | 133.08 CHF | −0.78% | 4.01 M | 1.00 | 32.07 | 4.15 CHF | −33.04% | 2.76% | Neutral |
| NOVNEENovartis AG TEMP | 245.77 B CHF | 132.56 CHF | −1.88% | 130 K | 0.45 | 31.95 | 4.15 CHF | −33.04% | 2.76% | Tiada penarafan |
| NOTNovartis AG | 245.77 B CHF | 132.760 CHF | −1.75% | 127 | 0.24 | 32.00 | 4.15 CHF | −33.04% | 2.76% | Neutral |
 ZEGAstraZeneca PLC | 239.39 B CHF | 155.416 CHF | +1.57% | 211 | 9.91 | 26.62 | 5.84 CHF | +18.22% | 1.70% | Beli |
 TN8Thermo Fisher Scientific Inc. | 213.87 B CHF | 546.250 CHF | −2.06% | 2 | 0.65 | 34.48 | 15.84 CHF | +14.93% | 0.26% | Beli |
 AMGAmgen Inc. | 211.44 B CHF | 388.337 CHF | +1.70% | 9 | 0.76 | 26.94 | 14.41 CHF | +39.89% | 2.08% | Neutral |
 GISGilead Sciences, Inc. | 176.9 B CHF | 134.099 CHF | −5.57% | 20 | 0.15 | — | −2.63 CHF | −151.18% | 1.86% | Beli |
 ABLAbbott Laboratories | 163.38 B CHF | 94.775 CHF | +6.44% | 631 | 30.05 | 41.86 | 2.26 CHF | −64.34% | 2.18% | Beli |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 154.8 B CHF | 33.873 CHF | +4.89% | 30 | 0.03 | 10.21 | 3.32 CHF | +21.39% | 2.92% | Neutral |
| NOVNovo Nordisk A/S Class B | 154.8 B CHF | 33.068 CHF | +0.66% | 248 | 0.14 | 10.27 | 3.22 CHF | +10.70% | 4.10% | Neutral |
 PFEPfizer Inc. | 143.45 B CHF | 23.577 CHF | −5.69% | 4.31 K | 10.28 | 40.34 | 0.58 CHF | −57.23% | 5.59% | Neutral |
 IUI1Intuitive Surgical, Inc. | 136.6 B CHF | 375.728 CHF | −4.11% | 25 | 1.59 | 54.38 | 6.91 CHF | +14.81% | 0.00% | Beli |
 DAPDanaher Corporation | 135.1 B CHF | 187.464 CHF | −1.94% | 1.65 K | 44.59 | 36.72 | 5.11 CHF | +31.91% | 0.65% | Beli |
 VX1Vertex Pharmaceuticals Incorporated | 113.78 B CHF | 439.008 CHF | −2.56% | 10 | 0.30 | 33.78 | 12.99 CHF | +14.99% | 0.00% | Beli |
 2M6Medtronic Plc | 109.74 B CHF | 85.457 CHF | −0.24% | 4 | 0.15 | 26.04 | 3.28 CHF | +11.14% | 2.72% | Beli |
 BRMBristol-Myers Squibb Company | 107.25 B CHF | 51.175 CHF | +1.34% | 10 | 0.03 | 13.57 | 3.77 CHF | +59.93% | 3.93% | Beli |
 SYKStryker Corporation | 105.69 B CHF | 257.002 CHF | +2.09% | 7 | 0.13 | 32.75 | 7.85 CHF | +29.36% | 1.04% | Beli |
 SNWSanofi SA | 92.58 B CHF | 77.442 CHF | +6.14% | 495 | 2.82 | 25.20 | 3.07 CHF | −36.38% | 4.90% | Beli |
| SANSanofi SA | 92.58 B CHF | 67.98 CHF | 0.00% | 450 | 0.13 | 22.12 | 3.07 CHF | −36.38% | 4.90% | Beli |
 0QFModerna, Inc. | 84.32 B CHF | 214.368 CHF | +8.91% | 2.19 K | 10.49 | — | −6.45 CHF | −8.21% | 0.00% | Neutral |
| MRNAModerna, Inc. | 84.32 B CHF | 161.56 CHF | −20.41% | 8 | — | — | −6.45 CHF | −8.21% | 0.00% | Neutral |
| MRNA.USDModerna, Inc. | 84.32 B CHF | 226.80 USD | 0.00% | 1.93 K | 1.55 | — | −6.45 CHF | −6.20% | 0.00% | Neutral |
 GS71GSK plc | 83.39 B CHF | 20.522 CHF | +1.52% | 3 | 0.04 | 17.34 | 1.18 CHF | −17.14% | 3.60% | Neutral |
 ESLEssilorLuxottica SA | 80.36 B CHF | 175.776 CHF | +9.63% | 100 | 1.13 | 35.58 | 4.94 CHF | +2.56% | 2.12% | Beli |
| EL1EssilorLuxottica SA | 80.36 B CHF | 179.30 CHF | 0.00% | 1.73 K | 1.57 | 36.29 | 4.94 CHF | +2.56% | 2.12% | Beli |
 MRKMerck KGaA | 60.03 B CHF | 138.411 CHF | +6.22% | 200 | 1.68 | 27.50 | 5.03 CHF | −18.23% | 1.46% | Beli |
 BSXBoston Scientific Corporation | 54.29 B CHF | 37.640 CHF | −0.39% | 500 | 2.74 | 19.06 | 1.97 CHF | +32.59% | 0.00% | Beli |
 CSJCSL Limited | 54.2 B CHF | 113.768 CHF | −1.02% | 386 | 1.17 | — | −4.25 CHF | −186.00% | 2.05% | Beli |
 UNCUCB S.A. | 49.28 B CHF | 254.278 CHF | +5.56% | 30 | 1.03 | 24.36 | 10.44 CHF | +62.96% | 0.36% | Beli |
 BAYNBayer AG | 48.9 B CHF | 43.46 CHF | 0.00% | 600 | 0.69 | — | −1.63 CHF | +49.77% | 0.20% | Beli |
| BAYNBayer AG | 48.9 B CHF | 50.052 CHF | −2.26% | 480 | 0.51 | — | −1.63 CHF | +49.77% | 0.20% | Beli |
 SHLSiemens Healthineers AG | 45.93 B CHF | 40.107 CHF | −2.47% | 4 | 0.06 | 22.01 | 1.82 CHF | +1.10% | 2.23% | Beli |
| SHLSiemens Healthineers AG | 45.93 B CHF | 41.12 CHF | +11.14% | 25 | 0.02 | 22.56 | 1.82 CHF | +1.10% | 2.23% | Beli |
 GALDGalderma Group AG | 45.37 B CHF | 189.334 CHF | −3.60% | 213 | 0.88 | 65.20 | 2.90 CHF | +110.71% | 0.18% | Beli |
| GALDGalderma Group AG | 45.37 B CHF | 191.75 CHF | −1.74% | 580.42 K | 1.03 | 66.03 | 2.90 CHF | +110.71% | 0.18% | Beli |
 LONNLonza Group AG | 45.09 B CHF | 663.4 CHF | −1.34% | 212.06 K | 1.42 | — | −1.55 CHF | −115.18% | 0.76% | Beli |
| LO3Lonza Group AG | 45.09 B CHF | 658.428 CHF | −2.15% | 34 | 0.12 | — | −1.55 CHF | −115.18% | 0.76% | Beli |
 IX1IDEXX Laboratories, Inc. | 44.99 B CHF | 561.726 CHF | +28.10% | 100 | 4.37 | 45.29 | 12.40 CHF | +23.43% | 0.00% | Beli |
 D8YSandoz Group Ltd | 36.14 B CHF | 83.263 CHF | +0.29% | 1.07 K | 1.70 | 70.72 | 1.18 CHF | +166.48% | 0.97% | Neutral |
| SDZSandoz Group Ltd | 36.14 B CHF | 83.78 CHF | +0.19% | 893 K | 0.61 | 71.16 | 1.18 CHF | +166.48% | 0.97% | Neutral |
 RVMDRevolution Medicines, Inc. | 34.99 B CHF | 150.462 CHF | −4.57% | 59 | 0.85 | — | −7.13 CHF | −99.36% | 0.00% | Beli kuat |
 2U3Alcon AG | 31.62 B CHF | 60.879 CHF | −3.84% | 1.21 K | 1.58 | 58.72 | 1.04 CHF | −44.92% | 0.44% | Beli |
| ALCAlcon AG | 31.62 B CHF | 61.30 CHF | −2.36% | 1.23 M | 1.27 | 59.12 | 1.04 CHF | −44.92% | 0.44% | Beli |
 ZOEZoetis, Inc. Class A | 30.13 B CHF | 65.569 CHF | +0.36% | 10 | 0.21 | 13.34 | 4.91 CHF | +6.56% | 2.38% | Neutral |
 DC4DexCom, Inc. | 26.97 B CHF | 64.471 CHF | −10.31% | 936 | 7.81 | 30.23 | 2.13 CHF | +49.03% | 0.00% | Beli kuat |
 IM8NInsmed Incorporated | 19.73 B CHF | 91.668 CHF | −4.48% | 48 | — | — | −2.35 CHF | +52.19% | 0.00% | Beli kuat |
 22UABioNTech SE Sponsored ADRDR | 18.62 B CHF | 70.648 CHF | −5.05% | 33 | 0.78 | — | −6.34 CHF | −399.64% | 0.00% | Beli |
 VTRSViatris, Inc. | 18.04 B CHF | 15.755 CHF | +4.80% | 74 | 1.31 | — | −0.29 CHF | +87.49% | 2.50% | Beli |
 DULAlnylam Pharmaceuticals, Inc | 17.64 B CHF | 138.579 CHF | −27.27% | 100 | 1.99 | 8.37 | 16.55 CHF | +8,543.33% | 0.00% | Beli |
 ZBHZimmer Biomet Holdings, Inc. | 17.17 B CHF | 76.0 CHF | +1.33% | 34 | 0.40 | 23.03 | 3.30 CHF | +2.53% | 0.87% | Neutral |
 QS51Straumann Holding AG | 17.12 B CHF | 106.125 CHF | −0.81% | 103 | 0.69 | 45.87 | 2.31 CHF | −5.94% | 0.93% | Beli |
| STMNStraumann Holding AG | 17.12 B CHF | 104.50 CHF | −1.28% | 363.31 K | 0.79 | 45.17 | 2.31 CHF | −5.94% | 0.93% | Beli |
 PHBNSonova Holding AG | 16.68 B CHF | 287.176 CHF | −1.86% | 128 | 0.34 | 39.77 | 7.22 CHF | −20.12% | 1.62% | Neutral |
| SOONSonova Holding AG | 16.68 B CHF | 288.0 CHF | −1.44% | 197.29 K | 1.42 | 39.88 | 7.22 CHF | −20.12% | 1.62% | Neutral |
 EX9Exelixis, Inc. | 14.51 B CHF | 53.452 CHF | +0.45% | 400 | 1.21 | 19.14 | 2.79 CHF | +47.64% | 0.00% | Beli |
 CBHDColoplast A/S Class B | 14.4 B CHF | 59.193 CHF | +1.18% | 2 K | 11.23 | 34.34 | 1.72 CHF | −14.44% | 4.40% | Neutral |
 WDH1Demant A/S | 9.42 B CHF | 45.623 CHF | +35.57% | 7 K | 40.70 | 48.03 | 0.95 CHF | −29.67% | 0.00% | Beli |
 QGENQIAGEN NV | 8.58 B CHF | 41.772 CHF | +40.91% | 10 | 0.10 | 26.25 | 1.59 CHF | +11.53% | 0.69% | Neutral |
 YDO1Madrigal Pharmaceuticals, Inc. | 7.6 B CHF | 358.641 CHF | −0.42% | 12 | 0.38 | — | −5.00 CHF | +51.78% | 0.00% | Beli kuat |
 HDP1Arrowhead Pharmaceuticals, Inc. | 7.12 B CHF | 50.112 CHF | −7.82% | 2 K | 17.39 | — | −1.81 CHF | −80.90% | 0.00% | Beli kuat |
 BANBBachem Holding AG Class B | 6.12 B CHF | 78.273 CHF | −3.74% | 12 | 0.15 | 39.38 | 1.99 CHF | +11.05% | 1.10% | Beli |
| BANBBachem Holding AG Class B | 6.12 B CHF | 79.70 CHF | −0.06% | 58.18 K | 0.78 | 40.10 | 1.99 CHF | +11.05% | 1.10% | Beli |
 OWXYpsomed Holding AG | 5.28 B CHF | 387.308 CHF | −4.22% | 1 | 0.04 | 23.76 | 16.30 CHF | +154.29% | 1.10% | Beli |
| YPSNYpsomed Holding AG | 5.28 B CHF | 394.4 CHF | −0.05% | 8.88 K | 0.79 | 24.20 | 16.30 CHF | +154.29% | 1.10% | Beli |
 1CGCRISPR Therapeutics AG | 4.11 B CHF | 40.056 CHF | −2.75% | 600 | 1.15 | — | −3.97 CHF | +10.71% | 0.00% | Beli |
 SFZNSiegfried Holding AG | 3.38 B CHF | 71.467 CHF | −3.66% | 32 | 0.16 | 18.28 | 3.91 CHF | +11.09% | 0.53% | Beli |
| SFZNSiegfried Holding AG | 3.38 B CHF | 72.00 CHF | −1.37% | 104.69 K | 0.94 | 18.41 | 3.91 CHF | +11.09% | 0.53% | Beli |
 IOVAIovance Biotherapeutics Inc | 3.22 B CHF | 7.100 CHF | −40.91% | 300 | — | — | −0.58 CHF | +40.09% | 0.00% | Beli |
 FIEFielmann Group AG | 3.19 B CHF | 36.668 CHF | +1.13% | 1 K | 6.49 | 15.75 | 2.33 CHF | +23.36% | 3.38% | Beli |
 TENTecan Group AG | 3.14 B CHF | 253.933 CHF | −4.60% | 56 | 1.10 | — | −9.16 CHF | −284.91% | 1.23% | Beli |
| TECNTecan Group AG | 3.14 B CHF | 257.6 CHF | −1.68% | 75.47 K | 0.91 | — | −9.16 CHF | −284.91% | 1.23% | Beli |
 AFXCarl Zeiss Meditec AG | 2.94 B CHF | 32.719 CHF | +1.21% | 100 | 0.21 | 32.70 | 1.00 CHF | −41.01% | 1.54% | Jual |
 MOVEMedacta Group SA | 2.48 B CHF | 106.4 CHF | −13.64% | 142.07 K | 4.92 | 29.74 | 3.58 CHF | −20.27% | 0.89% | Beli |
| 6MDMedacta Group SA | 2.48 B CHF | 106.788 CHF | −10.36% | 170 | 1.81 | 29.85 | 3.58 CHF | −20.27% | 0.89% | Beli |
 EZP1COMET Holding AG | 2.48 B CHF | 304.344 CHF | +2.26% | 4 | 0.08 | 132.65 | 2.29 CHF | −54.20% | 0.16% | Beli kuat |
| COTNCOMET Holding AG | 2.48 B CHF | 298.0 CHF | −0.13% | 57.39 K | 1.51 | 129.88 | 2.29 CHF | −54.20% | 0.16% | Beli kuat |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1.98 B CHF | 3.117 CHF | −4.45% | 4 K | 5.28 | — | −0.75 CHF | +48.25% | 0.00% | Beli |
 METNMetall Zug AG Class B | 1.8 B CHF | 835 CHF | 0.00% | 228 | 2.26 | — | −12.44 CHF | +56.17% | 0.00% | Neutral |
| NDH1Metall Zug AG Class B | 1.8 B CHF | 820.202 CHF | −0.27% | 2 | 0.21 | — | −12.44 CHF | +56.17% | 0.00% | Neutral |
 7VGSKAN Group AG | 1.61 B CHF | 73.514 CHF | +1.51% | 41 | 0.40 | 55.12 | 1.33 CHF | +85.35% | 0.31% | Beli kuat |
| SKANSKAN Group AG | 1.61 B CHF | 69.7 CHF | −0.99% | 33.43 K | 0.94 | 52.26 | 1.33 CHF | +85.35% | 0.31% | Beli kuat |
 MEDMedartis Holding AG | 1.51 B CHF | 109.6 CHF | +2.05% | 14.27 K | 0.78 | 91.44 | 1.20 CHF | — | 0.00% | Beli kuat |
 NVV1Novavax, Inc. | 1.44 B CHF | 8.008 CHF | −3.65% | 500 | 1.61 | — | −1.23 CHF | −168.74% | 0.00% | Beli |
 8H0PolyPeptide Group AG | 1.36 B CHF | 43.866 CHF | −0.37% | 400 | 0.36 | 108.53 | 0.40 CHF | — | 0.00% | Neutral |
| PPPGNEPolyPeptide Group AG TEMP | 1.36 B CHF | 44.00 CHF | +0.34% | 1.97 K | 0.19 | 108.86 | 0.40 CHF | — | 0.00% | Tiada penarafan |
| PPGNPolyPeptide Group AG | 1.36 B CHF | 40.05 CHF | −1.11% | 21.45 K | 0.97 | 99.08 | 0.40 CHF | — | 0.00% | Neutral |
 19TIdorsia Ltd. | 1.19 B CHF | 4.023 CHF | −8.69% | 100 | 0.08 | — | −1.11 CHF | −66.32% | 0.00% | Neutral |
| IDIAIdorsia Ltd. | 1.19 B CHF | 4.058 CHF | −3.38% | 997.2 K | 1.24 | — | −1.11 CHF | −66.32% | 0.00% | Neutral |